Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Di Carlo

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Scientific Reports|February 1, 2017
Drosophila CG3303 is an essential endoribonuclease linked to TDP-43-mediated neurodegenerationPietro Laneve, Lucia Piacentini, Assunta Maria Casale, et al.
AJR. American Journal of Roentgenology|May 20, 2004
Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patientsMassimo Venturini, Enzo Angeli, Marco Salvioni, et al.
Oncotarget|April 19, 2017
The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activityPietro Laneve, Agnese Po, Annarita Favia, et al.
Diabetes|January 5, 2002
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantationLorenzo Piemonti, Biagio Eugenio Leone, Rita Nano, et al.
Nature Communications|May 26, 2021
Epigenomic profiling of primate lymphoblastoid cell lines reveals the evolutionary patterns of epigenetic activities in gene regulatory architecturesRaquel García-Pérez, Paula Esteller-Cucala, Glòria Mas, et al.
Nano Letters|April 23, 2026
Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor RegrowthKristin Fichna, Maria Crespo-Cuadrado, Acsah Konuparamban, et al.
Annals of Surgical Oncology|January 13, 2012
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trialMichele Reni, Gianpaolo Balzano, Giuseppe Aprile, et al.
Nature Communications|August 17, 2023
LINE-1 regulates cortical development by acting as long non-coding RNAsDamiano Mangoni, Alessandro Simi, Pierre Lau, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 4, 2007
Cancer risk among the relatives of patients with pancreatic ductal adenocarcinomaMarco Del Chiaro, Alessandro Zerbi, Massimo Falconi, et al.
The Lancet. Oncology|June 1, 2005
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trialMichele Reni, Stefano Cordio, Carlo Milandri, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 1, 2017
Drosophila CG3303 is an essential endoribonuclease linked to TDP-43-mediated neurodegenerationPietro Laneve, Lucia Piacentini, Assunta Maria Casale, et al.
AJR. American Journal of Roentgenology|May 20, 2004
Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patientsMassimo Venturini, Enzo Angeli, Marco Salvioni, et al.
Oncotarget|April 19, 2017
The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activityPietro Laneve, Agnese Po, Annarita Favia, et al.
Diabetes|January 5, 2002
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantationLorenzo Piemonti, Biagio Eugenio Leone, Rita Nano, et al.
Nature Communications|May 26, 2021
Epigenomic profiling of primate lymphoblastoid cell lines reveals the evolutionary patterns of epigenetic activities in gene regulatory architecturesRaquel García-Pérez, Paula Esteller-Cucala, Glòria Mas, et al.
Nano Letters|April 23, 2026
Nanomotor-Assisted Intravesical Chemotherapy for Bladder Tumor Reduction and Suppression of Early Tumor RegrowthKristin Fichna, Maria Crespo-Cuadrado, Acsah Konuparamban, et al.
Annals of Surgical Oncology|January 13, 2012
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trialMichele Reni, Gianpaolo Balzano, Giuseppe Aprile, et al.
Nature Communications|August 17, 2023
LINE-1 regulates cortical development by acting as long non-coding RNAsDamiano Mangoni, Alessandro Simi, Pierre Lau, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 4, 2007
Cancer risk among the relatives of patients with pancreatic ductal adenocarcinomaMarco Del Chiaro, Alessandro Zerbi, Massimo Falconi, et al.
The Lancet. Oncology|June 1, 2005
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trialMichele Reni, Stefano Cordio, Carlo Milandri, et al.
Pageof 9